Bioactive porous bone graft compositions in synthetic containment
Bioactive porous bone graft implants in various forms suitable for use in bone tissue regeneration and/or repair, as well as methods of use are provided. The implants are formed of bioactive glass and have an engineered porosity. The implants may be contained in polymer for enhanced clinical results and better handling.
1. A porous, composite bone graft implant comprising:
a first component comprising a bioactive glass material in the form of a plurality of glass fibers, the plurality of glass fibers being randomly arranged throughout the implant; and
a second component comprising a polymeric material in the form of a coating encasing the first component;
each of the components having a different resorption capacity than the other component;
wherein the composite implant comprises a pore size distribution including pores characterized by pore diameters ranging from about 100 nanometer to about 1 millimeter.
2. The implant of claim 1 , wherein the bioactive glass is selected from the group consisting of sol gel derived bioactive glass, melt derived bioactive glass, silica based bioactive glass, silica free bioactive glass, phosphate based bioactive glass, crystallized bioactive glass, and bioactive glass containing trace elements.
3. The implant of claim 2 , wherein the bioactive glass comprises a silica free bioactive glass selected from the group consisting of borate based bioactive glass and phosphate based bioactive glass.
4. The implant of claim 2 , wherein the bioactive glass comprises a partially crystallized or fully crystallized bioactive glass.
5. The implant of claim 1 , wherein the first component further comprises bioactive glass granules.
6. The implant of claim 1 , wherein the first component is partially or fully sintered.
7. The implant of claim 1 , wherein the polymeric coating comprises a bioabsorbable polymer.
8. The implant of claim 1 , wherein the coating is porous.
9. The implant of claim 1 , wherein the polymeric coating comprises a combination of two or more polymers.
10. The implant of claim 1 , wherein at least one of the components is porous.
11. The implant of claim 5 , wherein each of the fibers includes a further coating.
12. The implant of claim 5 , wherein the polymeric coating comprises a woven layer surrounding the first component.
13. The implant of claim 5 , wherein each of the granules includes a further coating.
14. The implant of claim 1 , further including surface features on the implant to enhance anchorage of the implant.
15. The implant of claim 14 , wherein the surface features comprise fibers, granules, spikes, or surface roughenings.
16. The implant of claim 1 , further including a third component comprising a bioactive material in the form of granules.
17. The implant of claim 16 , wherein the granules are porous.
18. The implant of claim 16 , wherein the granules comprise bioactive glass, calcium sulfate, calcium phosphate, calcium carbonate, calcium hydroxide, or hydroxyapatite.
19. The implant of claim 16 , wherein the granules are contained in a coating and are configured to serve as surface enhancements to anchor the implant.
20. The implant of claim 16 , wherein the granules are partially or fully sintered.
21. The implant of claim 1 , further comprising an additive selected from the group consisting of medicine, trace element or metal, organic acid, mineralogical calcium source, antimicrobial, antiviral, vitamin, and x-ray opacifier.
22. The implant of claim 21 , wherein the trace element comprises copper, strontium, magnesium, or zinc.
23. The implant of claim 21 , wherein the organic acid comprises formic acid or hyaluronic acid.
24. The implant of claim 21 , wherein the mineralogical calcium source comprises tricalcium phosphate, hydroxyapatite, calcium carbonate, calcium hydroxide, or calcium sulfate.
25. The implant of claim 21 , wherein the antimicrobial comprises sodium or silver.
26. The implant of claim 21 , wherein the additive is in the form of a fiber or granule.
27. The implant of claim 1 , further comprising a biological agent.
28. The implant of claim 27 , wherein the biological agent comprises a bone morphogenic protein, a peptide, a bone growth factor, a platelet derived growth factor, a vascular endothelial growth factor, an insulin derived growth factor, a keratinocyte derived growth factor, a fibroblast derived growth factor, a stem cell, bone marrow, or platelet rich plasma.